CEWELD Powder PTA DUR 12

Hazard statements (CLP)

H317, H334, H341, H350, H360F, H373, H413

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause cancer. Suspected of causing genetic defects. May damage fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled May cause long lasting harmful effects to aquatic life

Hazard pictograms

GHS08

Signal word

Danger

Contains

nickel; cobalt

Hazard statements

H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 - Suspected of causing genetic defects. H350 - May cause cancer. H360F - May damage fertility. H373 - May cause damage to organs through prolonged or repeated exposure. H413 - May cause long lasting harmful effects to aquatic life.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing fume, dust. P280 - Wear respiratory protection, protective gloves, protective clothing, eye protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 - IF exposed or concerned: Get medical advice/attention. medical advice. P342+P311 - If experiencing respiratory symptoms: Call doctor, a POISON CENTER.

Additional information

Restricted to professional users.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Tungsten (7440-33-7) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Tungsten (7440-33-7) regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in Tungsten (7440-33-7) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Germ cell mutagenicity, Category 2 H341 Carcinogenicity, Category 1B H350 Reproductive toxicity, Category 1B H360F Specific target organ toxicity – Repeated exposure, Category 2 H373 Hazardous to the aquatic environment – Chronic Hazard, H413 Category 4 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause cancer. Suspected of causing genetic defects. May damage fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause long lasting harmful effects to aquatic life.